• USP36–Snail1 Control of Ribosome Stress in Cancer

  2026-09-04

  The reference study identifies a JNK–USP36–Snail1 pathway that allows solid tumor cells to preserve ribosome biogenesis and survive ribotoxic stress. Its findings explain why homoharringtonine is more effective in leukemia than in solid tumors and support combined inhibition of this adaptive axis with ribosome-targeting treatment.

• Recombinant Annexin V on Endothelial Thrombin Formation

  2026-09-04

  This 1994 study moved Annexin V research from model phospholipid vesicles to a physiologically relevant endothelial-cell surface. It quantified recombinant Annexin V binding to human endothelial cells and showed that the protein inhibits multiple coagulation-complex activities, clarifying how phosphatidylserine recognition can regulate thrombin generation.

• LMCD1 in TGF-β1-Driven Corneal Fibrosis

  2026-09-03

  The reference study identifies LMCD1 as a previously underappreciated regulator of TGF-β1-induced corneal fibroblast-to-myofibroblast differentiation. Its combined transcriptomic, molecular, and mouse-model evidence suggests that LMCD1 promotes α-SMA expression while participating in feedback control of TGF-β1 and SMAD3-associated signaling.

• EZ Cap™ Cy5 EGFP mRNA (5-moUTP) Workflows

  2026-09-03

  Build more informative mRNA delivery experiments by separating cellular uptake from functional protein expression in the same sample. This dual-reporter workflow supports nanoparticle screening, macrophage-focused studies, and quantitative translation analysis while exposing delivery bottlenecks that a single fluorescence readout can miss.

• Prestained Protein Marker: Triple-Color Workflow Guide

  2026-09-02

  The Prestained Protein Marker (Triple color, EDTA free, 10-250 kDa) provides visible size landmarks for SDS-PAGE and Western blot transfer checks across a broad molecular-weight range. It is intended for denaturing gel and membrane workflows, including Phosbind and fluorescent imaging applications, but should not be treated as standalone evidence of protein identity or native-PAGE performance.

• Ranolazine Workflows for Ischemia Research

  2026-09-02

  Use Ranolazine as both a late sodium current inhibitor and a metabolic probe in cardiac ischemia research. This workflow connects myocardial relaxation and substrate utilization assays with a carefully bounded exploratory framework for liver-cell autophagy and innate-immunity studies.

• DDM and the Dynamic Integrin Challenge

  2026-09-01

  Full-length αvβ3 integrin exists as a dynamic ensemble rather than a single druggable shape. This thought-leadership guide explains how n-Dodecyl-β-D-maltoside (DDM) can become a deliberate variable in integrin purification, cryo-EM sample preparation, folding assays, and translational screening—while emphasizing the controls needed to distinguish genuine biology from detergent-induced states.

• ABT-737: Mapping Mitochondrial Apoptosis

  2026-09-01

  ABT-737 is a selective BCL-2 protein inhibitor that helps researchers dissect mitochondrial apoptosis rather than merely measure cell death. This article connects its BH3-mimetic pharmacology with assay design, BAX/BAK biology, and interpretation of cancer-model responses.

• SINAT–VAB1 Control of Plant Autophagy

  2026-08-31

  A 2026 study in Arabidopsis identifies VAB1, a V-ATPase subunit, as a direct SINAT-associated regulator of autophagic vesicle degradation. By connecting SINAT-dependent ubiquitination of VAB1 with vacuolar acidification, the work distinguishes control of autophagic cargo breakdown from autophagosome formation and links this pathway to nutrient-stress tolerance and leaf senescence.

• Precision PCR for Neurodegeneration Research

  2026-08-31

  A translational strategy for using HyperFusion™ high-fidelity DNA polymerase to improve the accuracy, robustness, and interpretability of neurogenetic workflows inspired by pheromone-driven neurodegeneration research in C. elegans.

• Exemestane: Mechanism to Translational Strategy

  2026-08-30

  Exemestane is more than an aromatase assay reagent: its steroidal structure and irreversible enzyme inactivation create a powerful framework for connecting target engagement with estrogen-dependent phenotypes. This thought-leadership guide shows how translational researchers can position Exemestane within biomarker-led breast cancer research, compare it thoughtfully with SERM-based strategies, and design experiments that preserve mechanistic interpretability.

• Wnt-C59: Practical PORCN Inhibition Workflows

  2026-08-29

  Wnt-C59 enables precise testing of Wnt secretion, pathway activation, and Wnt-driven cancer phenotypes without relying solely on downstream pathway readouts. This guide translates its PORCN-focused activity into reproducible reporter, cholangiocarcinoma, and exploratory exosome workflows while clearly separating established evidence from future applications.

• PTT–CD47 Synergy in Oral Squamous Cell Carcinoma

  2026-08-28

  The reference study shows that photothermal therapy and CD47 blockade cooperate through two complementary mechanisms: photothermal treatment exposes calreticulin as an eat-me signal and remodels the extracellular matrix to improve macrophage access. Its integrated use of phagocytosis assays, immunogenic cell-death measurements, spatial imaging, and tumor-growth analysis provides a mechanistic framework for strengthening macrophage-based immunotherapy in oral squamous cell carcinoma.

• Apigenin: From HDAC Biology to Assay Design

  2026-08-28

  Apigenin research is strongest when chromatin regulation, apoptosis, reactive oxygen species production, and neuroinflammatory signaling are measured as connected events. This guide translates those mechanisms into a context-aware assay strategy for malignant mesothelioma and neurodegeneration studies.

• Angiotensin II: From GPCR Signals to Aneurysm Models

  2026-08-27

  Angiotensin II research can connect receptor-proximal signaling with vascular remodeling and aneurysm biology. This article presents a decision framework that combines Angiotensin II perturbation models with recent evidence on mitochondrial NAD+ deficiency and collagen III turnover.

7913 records 1/528 page Next 12345 下5页 Last page